Business · 10/06/2015
FDA Extends Comment Period for Homeopathic Product Regulation Proposal
The Food and Drug Administration (FDA) is extending the comment period for its homeopathic product regulation proposal, following requests from interested parties for additional time to submit comments, in response to a notice published in the Federal Register on March 27, 2015.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →